Capecitabine Alvogen Indications/Uses

Capecitabine is indicated for the adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer (see Pharmacology: Pharmacodynamics under Actions).
Capecitabine is indicated for the treatment of metastatic colorectal cancer (see Pharmacology: Pharmacodynamics under Actions).
Capecitabine is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen (see Pharmacology: Pharmacodynamics under Actions).
Capecitabine in combination with docetaxel (see Pharmacology: Pharmacodynamics under Actions) is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Capecitabine is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.